3 ms·
> That said, I am not sure whether regulatory approvals should take 5-15 years, when it seems like everyone's happy working through a coronavirus vaccine in les
by bsder 6y ago
> That said, I am not sure whether regulatory approvals should take 5-15 years, when it seems like everyone's happy working through a coronavirus vaccine in less than 1 year.
This has nothing to do with regulations and everything to do with how much money the companies are willing to throw at the problem.
If your budget is a billion+ dollars, a 30,000 person Phase III trial is no big deal. If your budget is a million+ dollars, a 30,000 person Phase III trial is painfully expensive.
The problem is that those 10K+ Phase III trials are where you first really see low probability problems.
- nickff 6y ago>"This has nothing to do with regulations and everything to do with how much money the companies are willing to throw at the problem." Regulations are the cause of the costs; I am not saying that regulatory compliance is a waste of money, but it definitely is a cost which should be considered. Delays also cost money and reduce return on investment (ROI), so I am sure the pharmaceutical companies do spend a great deal of money to expedite the process. Could all drug approvals go through faster if the pharma companies were willing to run larger trials? Would the FDA allow for these larger trials, and expedite the process for approval? What about rarer diseases, are they worth curing or treating on a timely basis?